Pageant for tribal women gives Idukki's Sudhalakshmi the wings to dream again
IDUKKI: The Muthuvan tribal community has for generations been dominated by males, with its women even discouraged from entering the public sphere. In many settlements, women continue to stay in seclusion huts (valaymapura) during menstruation and dash off into the jungle on a chance meeting with strangers.
However, in the remote tribal settlement of Kulachivayal, in Idukki's Kanthalloor panchayat, there is a woman who flies in the face of deep-rooted traditions: Sudhalakshmi. The 29-year-old is the only candidate from the tribal community in Idukki to participate in the 'Miss Kerala Forest Goddess' fashion and fitness competition, being organised by the Kochi-based Aurora Film Company.
Being born into a tradition-bound patriarchal tribal community, where women appearing in public places is considered taboo, it was through strenuous effort and hardship that Sudhalakshmi got selected to the event. 'Other tribal women from Muthuvan and Hill Pulaya communities settled in the Kanthalloor and Marayur areas had information of the event. But being unable to beak free of community rules, none of them applied,' Sudhalakshmi tells TNIE.
Most women in her community are educated up to class 10. 'Pursuing further studies is a real struggle because of the stigma attached to it, which is compounded by unequal gender norms,' says Sudhalakshmi. Her parents however, supported her dream of a higher education. After the auxiliary nursing midwifery (ANM) course from a private college in Adimali, Sudhalakshmi went on to complete her diploma in medical laboratory technology (DMLT) from Tamil Nadu.
Job offers followed, but from distant locations. Sudha couldn't bear to move away from her parents, who suffer from lifestyle diseases, and took a job with a private hospital in nearby Marayur, which paid her Rs 2,000 a month. But, following an accident, six months into the new job, she called it quits.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
7 minutes ago
- Economic Times
Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore
Global investment firm Carlyle group on Wednesday exited Indegene by divesting its entire 10.2 per cent stake in digital healthcare services for Rs 1,447 crore through open market transactions. ADVERTISEMENT According to the bulk deal data available on the NSE, US-based Carlyle group, through its arm CA Dawn Investments, sold more than 2.44 crore shares, amounting to a 10.20 per cent stake in Indegene. The shares were offloaded in the price range of Rs 591.02-591.84 apiece, taking the combined transaction value to Rs 1,447.17 crore. Meanwhile, Premji Invest's affiliate PI Opportunities AIF V, Capital group, Societe Generale, Luxembourg-based Eastbridge Group and Abakkus Asset Manager cumulatively bought 1.06 crore shares or 4.42 per cent stake in Indegene for Rs 627 crore. The shares were picked up in the price range of Rs 591-591.48 apiece, taking the aggregate deal value to Rs 626.85 crore. Details of the other buyers of Indegene's shares could not be ascertained on the National Stock Exchange (NSE). ADVERTISEMENT Shares of Indegene declined 4.07 per cent to close at Rs 594.50 per piece on the NSE. PE firm Carlyle group's clocked an impressive 31 per cent internal rate of return over a four-year period. This highly profitable divestment marks a pivotal moment, underscoring the immense potential of India's digital healthcare sector. ADVERTISEMENT In April 2021, Carlyle invested USD 122 million (Rs 917 crore) in Indegene by acquiring 45.5 million shares at Rs 201 each on the stock exchanges. Carlyle executed a phased exit as Indegene scaled its global operations and went public in May 2024. The shares were sold by the PE firm at Rs 452 apiece during the initial public offering, at Rs 618 per share in December 2024, and the final tranche at about Rs 591 each in June 2025, enabling Carlyle to secure significant returns amidst varying market conditions. (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
10 minutes ago
- Time of India
Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore
Global investment firm Carlyle group on Wednesday exited Indegene by divesting its entire 10.2 per cent stake in digital healthcare services for Rs 1,447 crore through open market transactions. According to the bulk deal data available on the NSE, US-based Carlyle group, through its arm CA Dawn Investments, sold more than 2.44 crore shares , amounting to a 10.20 per cent stake in Indegene. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like コンピュータでゲームをするのが好きなら、この新しいアドベンチャーゲームは必ずプレイすべきです。 アドベンチャーゲーム ゲームをプレイ Undo The shares were offloaded in the price range of Rs 591.02-591.84 apiece, taking the combined transaction value to Rs 1,447.17 crore. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0.00% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Meanwhile, Premji Invest's affiliate PI Opportunities AIF V, Capital group, Societe Generale, Luxembourg-based Eastbridge Group and Abakkus Asset Manager cumulatively bought 1.06 crore shares or 4.42 per cent stake in Indegene for Rs 627 crore. The shares were picked up in the price range of Rs 591-591.48 apiece, taking the aggregate deal value to Rs 626.85 crore. Live Events Details of the other buyers of Indegene's shares could not be ascertained on the National Stock Exchange (NSE). Shares of Indegene declined 4.07 per cent to close at Rs 594.50 per piece on the NSE. PE firm Carlyle group's clocked an impressive 31 per cent internal rate of return over a four-year period. This highly profitable divestment marks a pivotal moment, underscoring the immense potential of India's digital healthcare sector. In April 2021, Carlyle invested USD 122 million (Rs 917 crore) in Indegene by acquiring 45.5 million shares at Rs 201 each on the stock exchanges. Carlyle executed a phased exit as Indegene scaled its global operations and went public in May 2024. The shares were sold by the PE firm at Rs 452 apiece during the initial public offering, at Rs 618 per share in December 2024, and the final tranche at about Rs 591 each in June 2025, enabling Carlyle to secure significant returns amidst varying market conditions.
News18
an hour ago
- News18
IIT Delhi, AIIMS To Establish Centre Of Excellence For AI In Healthcare
Last Updated: The AI-CoE aims to develop AI-based solutions that support key national health programmes., IIT Delhi stated. IIT Delhi and AIIMS Delhi have entered into a Memorandum of Understanding (MoU) to create a Centre of Excellence for AI in Healthcare (AI-CoE). The MoU was signed by Prof. M. Srinivas, Director of AIIMS Delhi, and Prof. Rangan Banerjee, Director of IIT Delhi, during a ceremony at IIT Delhi. The AI-CoE aims to develop AI-based solutions that support key national health programmes. Last year, the Ministry of Education awarded the two institutes a grant of Rs 330 crore under the 'Make AI in India, Make AI Work for India' initiative, following a rigorous and competitive selection process. The proposed Centre of Excellence will serve as the implementation vehicle for this grant. 'This MoU marks the beginning of far-reaching collaborative research that has the potential to change the face of healthcare in the country," Prof. M. Srinivas, Director, AIIMS Delhi said. Prof. Rangan Banerjee, Director, IIT Delhi said, 'A partnership between AIIMS and IIT Delhi has the potential to transform Artificial Intelligence for affordable healthcare. We are delighted to be shaping this national center of excellence and hope that our output will impact the lives of Indians." Dr. Krithika Rangarajan, Chief Project Manager, who will lead the initiative from AIIMS Delhi, said, 'As we venture into this exciting new space, we look forward to guiding the marriage of healthcare with technology. We remain focused on keeping patients at the center of this effort and hope to build mechanisms that would benefit every citizen of the country." Prof. Chetan Arora, Chief Project Manager, who will lead the AI-CoE from IIT Delhi, said, 'We are excited to be part of this AI-CoE. The CoE will serve as a key research and resource center at the national and international level and aims to revolutionise the national public health system using indigenously developed AI systems and solutions. Our aim is to develop cuttingedge AI solutions to upscale health services, upskill our healthcare providers, and improve the accessibility of quality healthcare to remote and marginalised sections of our population."
